These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8601331)

  • 21. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On standardization of the radioreceptor assay for anti-thyrotropin receptor antibody.
    Tamaki H; Amino N; Miyai K
    Clin Chem; 1988 Aug; 34(8):1662. PubMed ID: 2900087
    [No Abstract]   [Full Text] [Related]  

  • 23. [Blockade of the renin-angiotensin-aldosterone system in Graves' disease].
    García JL; Etayo BZ; Calvo JI
    Endocrinol Nutr; 2009 Oct; 56(8):435-6. PubMed ID: 19959156
    [No Abstract]   [Full Text] [Related]  

  • 24. The negative correlation between thyrotropin receptor-stimulating antibodies and bone mineral density in postmenopausal patients with Graves' disease.
    Amashukeli M; Korinteli M; Zerekidze T; Jikurauli N; Shanava S; Tsagareli M; Giorgadze E
    J Investig Med; 2013 Jun; 61(5):842-7. PubMed ID: 23612147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The immune and nonimmune genesis of goiter].
    Grigorie D
    Endocrinologie; 1990; 28(3-4):95-106. PubMed ID: 1983320
    [No Abstract]   [Full Text] [Related]  

  • 26. [Graves disease in pregnancy a risk for the child. Maternal TSH receptor antibodies can cause fetal and neonatal thyrotoxicosis].
    Roos M; Sjöberg O; Axelsson O; Karlsson FA
    Lakartidningen; 2008 Jan 16-22; 105(3):120-4. PubMed ID: 18290505
    [No Abstract]   [Full Text] [Related]  

  • 27. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay.
    Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP
    Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of heterogeneous thyroid-stimulating antibodies in sera from individual Graves' patients as shown by synthesized thyrotropin receptor peptide application: evidence showing two independent epitopes and a possible recognition of two epitopic regions by one antibody molecule.
    Sugawa H; Akamizu T; Kosugi S; Ueda Y; Ohta C; Okuda J; Mori T
    Eur J Endocrinol; 1995 Sep; 133(3):283-93. PubMed ID: 7581943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of variability in Graves' disease: stimulatory TSH-receptor antibodies bind to the TSH-receptor in a continued, non-pulsatile and non-chaotic fashion.
    Schuppert F; Diegelmann B; Geest T; Wagner TO; von zur Mühlen A
    Chronobiologia; 1994; 21(1-2):21-32. PubMed ID: 7924634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preserved activation of thyrotropin receptor antibody to stimulate thyroid function despite long-term treatment in euthyroid patients with Graves' disease.
    Akuzawa M; Murakami M; Yamada M; Satoh T; Shimizu H; Mori M
    Eur J Endocrinol; 1998 Mar; 138(3):281-5. PubMed ID: 9539302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [TSH-receptor antibodies: immunoanalytical characteristics].
    Massart C
    Ann Biol Clin (Paris); 2015; 73(2):221-4. PubMed ID: 25847746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thyrotropin receptor antibodies (TRAb) as a test of surgical treatment effectiveness in Graves-Basedow's diseases].
    Bojarska-Szmygin A; Ciechanek R; Jezierska B; Zaorska-Rajca J
    Pol Merkur Lekarski; 2002 Sep; 13(75):196-9. PubMed ID: 12474569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: retrospective clinical survey.
    Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Mori K; Hori H; Abe K
    J Endocrinol Invest; 1996 Nov; 19(10):682-6. PubMed ID: 9007700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Back to the drawing board for antigens in endocrine ophthalmopathy?
    Ludgate M
    Dev Ophthalmol; 1993; 25():86-92. PubMed ID: 7689491
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical significance of classification of Graves' disease according to the characteristics of TSH receptor antibodies.
    Kim WB; Chung HK; Park YJ; Park DJ; Lee HK; Cho BY
    Korean J Intern Med; 2001 Sep; 16(3):187-200. PubMed ID: 11769578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of infiltrative ophthalmopathy in parallel with decrease of thyroid-stimulating antibody (TSAb) activity in two patients with hypothyroid Graves' disease.
    Tamaki H; Amino N; Iwatani Y; Miyai K
    J Endocrinol Invest; 1989 Jan; 12(1):47-53. PubMed ID: 2568374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid controversy--stimulating antibodies.
    Davies TF; Roti E; Braverman LE; DeGroot LJ
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3777-85. PubMed ID: 9814446
    [No Abstract]   [Full Text] [Related]  

  • 39. TSH receptor antibody in autoimmune thyroiditis and its clinical significance.
    Chang TC; Chen FW; Chang CC; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1986 Aug; 85(8):748-54. PubMed ID: 2878965
    [No Abstract]   [Full Text] [Related]  

  • 40. Why does the patient with Graves' disease remain euthyroid/mildly hyperthyroid following total thyroidectomy--the role of thyrotropin receptor antibodies (TRAb) and vestigial remnants of the thyroglossal tract.
    Cigrovski-Berković M; Solter D; Solter M
    Acta Clin Croat; 2008 Sep; 47(3):171-4. PubMed ID: 19175067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.